Our 2018 Revenue ($182 M) is greater than our Market Cap ($100 M). Wait for some positive news and market will wake up. Hope we get also some partnerships or 5G announcements.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling